Foundation Medicine Announces Presentations at the AACR Annual Meeting 2016
The company's molecular information products, FoundationOne® for solid tumors and FoundationOne® Heme for hematologic malignancies and sarcomas, provide a comprehensive genomic profile to identify the molecular alterations in a patient's cancer. The data to be presented at AACR add to an ever-increasing body of evidence supporting the benefits of comprehensive genomic profiling in cancer care.
The schedule for mini-symposium presentations by
Date and Time: |
Title: The landscape of tumor mutation load across the entire spectrum of human cancer derived from 60,000 patients |
Abstract Number: 2629 |
Location: |
Session: Genomic Landscapes |
Presenter: |
Date and Time: |
Title: Activation mechanism of oncogenic C-helix shifting mutations in BRAF, EGFR, and HER2 |
Abstract Number: 4374 |
Location: |
Session: Oncogenic Cell Signaling: Mechanisms and Translational Insight |
Presenter: |
Collaborator: |
The schedule for poster presentations by
Date and Time: |
Title: Detection of a novel ALK fusion variant in lung adenocarcinoma using a comprehensive genomic analysis |
Abstract Number: 1144 |
Poster Board Number: 24 |
Poster Display Location: Section 8 |
Session: Oncogene Function, Regulation, and Targeting |
Presenter: |
Collaborators: |
Date and Time: |
Title: Enrichment of targetable mutations in the relapsed neuroblastoma genome |
Abstract Number: 2431 |
Poster Board Number: 8 |
Poster Display Location: Section 30 |
Session: Pediatric Cancer Genomics, Genetics, and Epigenetics |
Presenter: |
Collaborators: Children's Hospital of |
Date and Time: |
Title: Genomic profiling of 1239 diverse pediatric cancers identifies novel discoveries across tumors |
Abstract Number: LB-178 |
Poster Board Number: 4 |
Poster Display Location: Section 11 |
Session: |
Presenter: |
Date and Time: |
Title: Delivery of point-of-care management to patients with gynecologic malignancies using comprehensive genomic profiling |
Abstract Number: 3183 |
Poster Board Number: 20 |
Poster Display Location: Section 23 |
Session: Molecular Classification and Genomic Applications |
Presenter: |
Collaborators: |
Date and Time: |
Title: Rigorous validation of a clinical circulating tumor DNA assay for cancer molecular profiling |
Abstract Number: 3965 |
Poster Board Number: 25 |
Poster Display Location: Section 23 |
Session: Circulating Biomarkers 3 / Immune Biomarkers |
Presenter: |
Collaborator: |
Date and Time: |
Title: Broad analysis of recurrent somatic mutations in cancer reveals a common novel non-coding mutation in the promoter of PMS2 associated with greatly increased tumor mutation load |
Abstract Number: 3576 |
Poster Board Number: 1 |
Poster Display Location: Section 5 |
Session: Genetic Instability in Cancer: Molecular Basis and Tools |
Presenter: |
Collaborator: |
Date and Time: |
Title: Subtypes of urothelial carcinoma of the urinary bladder defined by genomic alteration combinations predict clinical characteristics |
Abstract Number: LB-328 |
Poster Board Number: 23 |
Poster Display Location: Section 10 |
Session: |
Presenter: |
About
Cautionary Note Regarding Forward-Looking Statements
This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements regarding the benefits of comprehensive genomic profiling, including FoundationOne and FoundationOne Heme in cancer care. All such forward-looking statements are based on management's current expectations of future events and are subject to a number of risks and uncertainties that could cause actual results to differ materially and adversely from those set forth in or implied by such forward-looking statements. These risks and uncertainties include the risks described under the caption "Risk Factors" in
View source version on businesswire.com: http://www.businesswire.com/news/home/20160317005167/en/
Media Contact:
dan@purecommunicationsinc.com
or
Investor Contact:
ir@foundationmedicine.com
or
matt@purecommunicationsinc.com
Source:
News Provided by Acquire Media